| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/10/2000 | WO1999058139A3 Methods for detecting and inhibiting angiogenesis |
| 02/10/2000 | WO1999045910A3 Methods and compositions for treating and preventing mucositis |
| 02/10/2000 | WO1999045126A3 Enhanced prodrug activation |
| 02/10/2000 | WO1999042481A3 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON β-CATENIN, AND THE PRODUCTION AND USE THEREOF |
| 02/10/2000 | WO1999041376A3 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 02/10/2000 | DE19835611A1 Neuartige Phospholipide mit synthetischen, ungesättigten Alkyl- und Acylketten Novel synthetic phospholipids with unsaturated alkyl and acyl chains |
| 02/10/2000 | DE19835368C1 Verfahren zur Herstellung einer Knorpelzellsuspension A process for the preparation of a cartilage cell suspension |
| 02/10/2000 | DE19835324A1 Cyclopentabenzofuran-Derivate und ihre Verwendung Cyclopentabenzofuran derivatives and their use |
| 02/10/2000 | CA2339099A1 Sulfonamide derivatives |
| 02/10/2000 | CA2339096A1 Modulation of apoptosis |
| 02/10/2000 | CA2339094A1 Macrophage scavenger receptor antagonists |
| 02/10/2000 | CA2339093A1 Cholinergic agents in the treatment of presbyopia |
| 02/10/2000 | CA2339091A1 Sulphonamide derivatives |
| 02/10/2000 | CA2339071A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 02/10/2000 | CA2338930A1 Heterocyclic sulphonamide derivatives |
| 02/10/2000 | CA2338916A1 Amide, carbamate, and urea derivatives |
| 02/10/2000 | CA2338864A1 Sulphonamide derivatives |
| 02/10/2000 | CA2338745A1 Heterocyclyl sulphonamide derivatives |
| 02/10/2000 | CA2338643A1 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 02/10/2000 | CA2338490A1 Diketoacid-derivatives as inhibitors of polymerases |
| 02/10/2000 | CA2338396A1 Ultrasonic enhancement of drug injection |
| 02/10/2000 | CA2338330A1 Use of moclobemide for treating certain phsychiatric and medical disorders |
| 02/10/2000 | CA2338019A1 Prostate derived ets factor |
| 02/10/2000 | CA2336802A1 Substituted quinazoline derivatives |
| 02/10/2000 | CA2336549A1 Methods for treating conditions modulated by lactosylceramide |
| 02/10/2000 | CA2336543A1 Isoforms of human calcium sensing receptor |
| 02/10/2000 | CA2335656A1 Human cytoskeletal proteins |
| 02/10/2000 | CA2335643A1 C7f2-a novel potassium channel .beta.-subunit |
| 02/10/2000 | CA2335077A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/09/2000 | EP0978561A1 Antisense oligonucleotides for the inhibition of VEGF expression |
| 02/09/2000 | EP0978517A2 Triazolopurines, process for their preparation and their use as medicaments |
| 02/09/2000 | EP0978287A1 MEDICINAL COMPOSITION CONTAINING gp34 BINDING INHIBITOR AS THE ACTIVE INGREDIENT |
| 02/09/2000 | EP0978285A1 Pharmaceutical composition of hedgehog proteins and use thereof. |
| 02/09/2000 | EP0977887A2 Member of the tnf family useful for treatment and diagnosis of disease |
| 02/09/2000 | EP0977873A1 Method for cleavage of fusion proteins |
| 02/09/2000 | EP0977856A1 Lag-3 splice variants |
| 02/09/2000 | EP0977855A2 Polypeptides associated with activator receptors and their biological applications |
| 02/09/2000 | EP0977853A1 Secreted proteins and polynucleotides encoding them |
| 02/09/2000 | EP0977852A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 02/09/2000 | EP0977844A1 Mammal neuronal acid sensing cationic channel, cloning and applications thereof |
| 02/09/2000 | EP0977842A1 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors |
| 02/09/2000 | EP0977834A2 Human serine protease precursor |
| 02/09/2000 | EP0977777A1 A novel th2-specific gene |
| 02/09/2000 | EP0977767A1 Aminooxy-modified oligonucleotides |
| 02/09/2000 | EP0977759A1 Crf antagonistic thiophenopyridines |
| 02/09/2000 | EP0977758A1 Spiro-azacyclic derivatives and their use as therapeutic agents |
| 02/09/2000 | EP0977756A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 02/09/2000 | EP0977755A1 Heterocyclic compounds and their preparation and use |
| 02/09/2000 | EP0977751A1 Somatostatin agonists |
| 02/09/2000 | EP0977750A1 Farnesyltransferase inhibiting quinazolinones |
| 02/09/2000 | EP0977748A1 Substituted benzopyran derivatives for the treatment of inflammation |
| 02/09/2000 | EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 02/09/2000 | EP0977743A1 Protease inhibitors |
| 02/09/2000 | EP0977738A2 Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer |
| 02/09/2000 | EP0977737A1 Crf antagonistic quino- and quinazolines |
| 02/09/2000 | EP0977733A1 Arylsulfonylamino hydroxamic acid derivatives |
| 02/09/2000 | EP0977582A1 Pharmaceutical combined preparations containing erythropoietin and iron preparations |
| 02/09/2000 | EP0977578A1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 02/09/2000 | EP0977575A1 THE USE OF $g(a)-METHYL-P-TYROSINE TO INHIBIT MELANIN PRODUCTION IN IRIS MELANOCYTES |
| 02/09/2000 | EP0977573A1 Use of an nk-1 receptor antagonist and an ssri for treating obesity |
| 02/09/2000 | EP0977572A1 Use of nk-1 receptor antagonists for treating eating disorders |
| 02/09/2000 | EP0977571A1 Piperazine derivatives for treating bone deficit conditions |
| 02/09/2000 | EP0977568A1 Benzocycloheptathiophene compounds |
| 02/09/2000 | EP0977564A1 Forskohlin for promoting lean body mass |
| 02/09/2000 | EP0977560A1 IBUPROFEN THIOESTERS AS INHIBITORS OF Nf-kappaB-DEPENDENT PAIN AND INFLAMMATION MEDIATOR FORMATION |
| 02/09/2000 | EP0977559A1 Enhanced anti-cancer agent delivery to solid tumors by primer compounds |
| 02/09/2000 | EP0977558A2 Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors |
| 02/09/2000 | EP0977550A1 Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product |
| 02/09/2000 | EP0822934B1 Antithrombotic amidinotetrahydropyridylalanine derivatives |
| 02/09/2000 | EP0793671B1 Phenylsubstituted 4-azasteroid fluoroderivatives |
| 02/09/2000 | EP0608313B1 Formulations of blood clot-polymer matrix for delivery of osteogenic proteins |
| 02/09/2000 | CN1244213A Pressure-mediated intracellular delivery of molecules or microparticles |
| 02/09/2000 | CN1244124A Amorphous benzothiophenes, methods of preparation, and methods of use |
| 02/09/2000 | CN1244123A Kit for inhibiting the growth of cancers, comprising a chemotherapeutic agent and a benzimdazole, and optionally a protentiator |
| 02/09/2000 | CN1244122A Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 02/09/2000 | CN1243749A Inhibitor |
| 02/09/2000 | CN1049222C Propiophenone derivative and processes for preparing the same |
| 02/09/2000 | CN1049217C 1,5-benzodiazepine derivatives |
| 02/09/2000 | CN1049116C Process for treating cardiovascular hypertrophy and hyperplasia |
| 02/08/2000 | US6022984 Efficient synthesis of furan sulfonamide compounds useful in the synthesis of new IL-1 inhibitors |
| 02/08/2000 | US6022981 Key intermediates in synthesizing 5,10-disubstituted porphyrin compounds or other 5,10-disubstituted polypyrrolic macrocycles. |
| 02/08/2000 | US6022978 Benzimidazole derivatives |
| 02/08/2000 | US6022977 Dynamic resolution of isoxazoline thioesters to isoxazoline carboxylic acids |
| 02/08/2000 | US6022971 Azetidines |
| 02/08/2000 | US6022900 Preventing and ameliorating cachexia; treating whole body nitrogen loss associated with catabolic illness by inhibiting synthesis of urea from plasma arginine |
| 02/08/2000 | US6022899 Effective inhibitors of the cellular sodium proton antiporter |
| 02/08/2000 | US6022898 Metalloproteinase inhibitors |
| 02/08/2000 | US6022886 Endothelin receptor antagonists |
| 02/08/2000 | US6022878 Inhibitors of rotamase enzyme activity |
| 02/08/2000 | US6022873 Metalloproteinase inhibitors |
| 02/08/2000 | US6022862 Use of pseudopterosins for promoting wound healing |
| 02/08/2000 | US6022848 Inhibitor of stem cell proliferation and uses thereof |
| 02/08/2000 | US6022694 Assay for ligands to tyrosine kinase receptors |
| 02/08/2000 | US6022555 Animal feed containing carboxylic acids |
| 02/08/2000 | US6022541 Immunological preparation for concurrent specific binding to spatially exposed regions of vascular permeability factor bound in-vivo to a tumor associated blood vessel |
| 02/08/2000 | US6022538 Administering adriamycin or cisplatin, and cell therapy cells modified by in vitro treatment with a cytokine and gamma irradiation at a dose to irreversibly arrest cell proliferation but not interfere with the cytotoxic activity |
| 02/08/2000 | CA2014467C 3-substituted-2-oxindole derivatives |
| 02/03/2000 | WO2000005388A1 Genes of the dead box protein family, their expression products and use |
| 02/03/2000 | WO2000005375A1 Gbs toxin receptor |
| 02/03/2000 | WO2000005370A1 Orphan cytokine receptor |